Lista de obras - E Peverelli - Dominio Público Uruguay

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

artículo científico publicado en 2017

Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients.

artículo científico publicado en 2009

Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR.

artículo científico publicado en 2014

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells.

artículo científico publicado en 2017

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

artículo científico publicado en 2019

Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).

artículo científico publicado en 2013

Deciphering the specific role of G(αi/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants

artículo científico publicado en 2013

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement

artículo científico publicado en 2015

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors

artículo científico publicado en 2017

Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands

artículo científico publicado en 2005

Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells.

artículo científico publicado en 2014

Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation.

artículo científico publicado en 2014

Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.

artículo científico publicado en 2012

HESX1 expression in human normal pituitaries and pituitary adenomas.

artículo científico publicado en 2006

High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

artículo científico publicado en 2007

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.

artículo científico publicado en 2015

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).

artículo científico publicado en 2011

Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2.

artículo científico publicado en 2006

Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function

artículo científico publicado en 2009

Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.

artículo científico publicado en 2004

Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.

artículo científico publicado en 2004

Pseudohypoparathyroidism andGNASEpigenetic Defects: Clinical Evaluation of Albright Hereditary Osteodystrophy and Molecular Analysis in 40 Patients

article

Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.

artículo científico publicado en 2013

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.

artículo científico publicado en 2013

Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells

artículo científico publicado en 2012

Specific roles of Giprotein family members revealed by dissecting SST5 coupling in human pituitary cells

artículo científico publicado en 2014

The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways.

artículo científico publicado en 2009

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion.

artículo científico publicado en 2015

cAMP in the pituitary: an old messenger for multiple signals.

artículo científico publicado en 2013

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells

scientific article published on 08 August 2018

Lista de obras de E Peverelli

A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment

Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients.

Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR.

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells.

Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation

Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).

Deciphering the specific role of G(αi/o) isoforms: functional selective oxytocin ligands and somatostatin SST5 receptor mutants

Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement

Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors

Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands

Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells.

Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation.

Filamin-A is essential for dopamine d2 receptor expression and signaling in tumorous lactotrophs.

HESX1 expression in human normal pituitaries and pituitary adenomas.

High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells

Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas.

Macroautophagy and the proteasome are differently involved in the degradation of alpha-synuclein wild type and mutated A30P in an in vitro inducible model (PC12/TetOn).

Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2.

Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function

Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.

Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.

Pseudohypoparathyroidism andGNASEpigenetic Defects: Clinical Evaluation of Albright Hereditary Osteodystrophy and Molecular Analysis in 40 Patients

Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.

Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.

Specific roles of G(i) protein family members revealed by dissecting SST5 coupling in human pituitary cells

Specific roles of Giprotein family members revealed by dissecting SST5 coupling in human pituitary cells

The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways.

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion.

cAMP in the pituitary: an old messenger for multiple signals.

cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells